Chris Bolger
About Chris Bolger
Chris Bolger is the Senior District Business Manager at Bristol-Myers Squibb in New Jersey, United States, leading a team of 8 Cardiovascular Specialty Representatives.
Current Role at Bristol-Myers Squibb
Chris Bolger is the Senior District Business Manager at Bristol-Myers Squibb, a role he has held since March 2014. He currently leads a team of 8 Cardiovascular Specialty Representatives who cover territories in New Jersey, Delaware, and Maryland. His responsibilities include overseeing the team, ensuring effective engagement with both office and hospital-based specialists, and driving business objectives within the district.
Previous Roles at Bristol-Myers Squibb
Chris Bolger has a long tenure at Bristol-Myers Squibb, holding various positions over the years. From 2011 to 2014, he was a Senior District Business Manager. Between 2009 and 2011, he served as a District Business Manager. Prior to that, he was an Associate Manager in Regional Operations from 2007 to 2009. Chris also worked as a Cardiovascular Risk Specialist from 2004 to 2007, and as a Senior Territory Business Manager from 1999 to 2004. Each of these roles was based in New Jersey, where he focused on building strong relationships with healthcare providers and advancing the company’s objectives.
Experience in Team Leadership
In his current role, Chris Bolger leads a team of 8 Cardiovascular Specialty Representatives. His leadership extends across regions including New Jersey, Delaware, and Maryland. Chris's extensive experience in managing teams that engage with both office-based and hospital-based specialists underscores his expertise in fostering professional development, optimizing team performance, and achieving departmental goals.
Early Career as Executive Recruiter
Before his tenure at Bristol-Myers Squibb, Chris Bolger worked as an Executive Recruiter at Jm & Company from 1994 to 1997. In this role, he gained valuable experience in talent acquisition and executive recruitment, skills that have likely contributed to his effective leadership and team management in his subsequent roles in the pharmaceutical industry.